An analysis found that 18.3% of relapse ALL cases (n = 71) had sequence or deletion mutations of CREBBP, which resulted in truncated alleles or detrimental substitutions in conserved residues of the HAT domain [68]. The gene discussed is CREBBP; the disease is acute lymphoblastic leukemia.